Correction: Multi-level interactions between the nuclear receptor TRa1 and the WNT effectors b-catenin/Tcf4 in the intestinal epithelium (PLoS ONE 7, 4 (e34162) DOI: 10.1371/journal.pone.0034162);Multi-level interactions between the nuclear receptor TRα1 and the WNT effectors β-catenin/Tcf4 in the intestinal epithelium

PLoS ONE

Volumn 7, Issue 4, 2012, Pages

  Sirakov, Maria ^a,c   Skah, Seham ^a,d   Lone, Imtiaz Nisar ^b   Nadjar, Julien ^a,d   Angelov, Dimitar ^b   Plateroti, Michelina ^a,d  

^a Univ Lyon 1   (France)

^b UNIVERSITÉ LYON 1   (France)

^c UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^d CENTRE DE GÉNÉTIQUE MOLÉCULAIRE ET CELLULAIRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; DNA; LUCIFERASE; PROTEIN TCF4; PROTEIN TRALPHA1; T CELL FACTOR PROTEIN; THYROID HORMONE RECEPTOR; UNCLASSIFIED DRUG; WNT PROTEIN; BASIC HELIX LOOP HELIX LEUCINE ZIPPER TRANSCRIPTION FACTOR; LIGAND; TCF4 PROTEIN, MOUSE; THYROID HORMONE RECEPTOR ALPHA; WNT3A PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL NUCLEUS; CELL STRAIN CACO 2; CONTROLLED STUDY; DNA SEQUENCE; GENE OVEREXPRESSION; GENE TARGETING; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INTESTINE EPITHELIUM; INTESTINE MUCOSA; INTESTINE TUMOR; MOLECULAR MECHANICS; MOUSE; NEWBORN; NONHUMAN; PROTEIN DNA BINDING; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REPORTER GENE; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; ANIMAL; CHROMATIN; CYTOLOGY; DNA RESPONSIVE ELEMENT; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; METABOLISM; PATHOLOGY; PROTEIN BINDING;

MUS;

ANIMALS; BASIC HELIX-LOOP-HELIX LEUCINE ZIPPER TRANSCRIPTION FACTORS; BETA CATENIN; CACO-2 CELLS; CELL NUCLEUS; CHROMATIN; GENE EXPRESSION REGULATION; HUMANS; INTESTINAL MUCOSA; INTESTINAL NEOPLASMS; LIGANDS; MICE; PROTEIN BINDING; RESPONSE ELEMENTS; THYROID HORMONE RECEPTORS ALPHA; TRANSCRIPTION, GENETIC; WNT3A PROTEIN;

EID: 84859219442     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0093418     Document Type: Erratum

References (55)

1. Barker N, Ridgway RA, van Es JH, van de Wetering M, Begthel H, et al. (2009) Crypt stem cells as the cells-of-origin of intestinal cancer. Nature 457: 608-611.
2. Stappenbeck TS, Wong MH, Saam JR, Mysorekar IU, Gordon JI, (1998) Notes from some crypt watchers: regulation of renewal in the mouse intestinal epithelium. Curr Opin Cell Biol 10: 702-709.
3. Sancho E, Batlle E, Clevers H, (2004) Signaling pathways in intestinal development and cancer. Annu Rev Cell Dev Biol 20: 695-723.
4. Buske P, Galle J, Barker N, Aust G, Clevers H, et al. (2011) A comprehensive model of the spatio-temporal stem cell and tissue organisation in the intestinal crypt. PLoS Comput Biol 7: e1001045.
5. Kress E, Samarut J, Plateroti M, (2009) Thyroid hormones and the control of cell proliferation or cell differentiation: paradox or duality? Mol Cell Endocrinol.
6. van der Flier LG, Clevers H, (2009) Stem cells, self-renewal, and differentiation in the intestinal epithelium. Annu Rev Physiol 71: 241-260.
7. Radtke F, Clevers H, Riccio O, (2006) From gut homeostasis to cancer. Curr Mol Med 6: 275-289.
8. Humphries A, Wright NA, (2008) Colonic crypt organization and tumorigenesis. Nat Rev Cancer 8: 415-424.
9. Kress E, Skah S, Sirakov M, Nadjar J, Gadot N, et al. (2010) Cooperation between the thyroid hormone receptor TRalpha1 and the WNT pathway in the induction of intestinal tumorigenesis. Gastroenterology 138: 1863-1874.
10. Sirakov M, Plateroti M, (2011) The thyroid hormones and their nuclear receptors in the gut: From developmental biology to cancer. Biochim Biophys Acta 1812: 938-946.
11. Flamant F, Samarut J, (2003) Thyroid hormone receptors: lessons from knockout and knock-in mutant mice. Trends Endocrinol Metab 14: 85-90.
12. Yen PM, Ando S, Feng X, Liu Y, Maruvada P, et al. (2006) Thyroid hormone action at the cellular, genomic and target gene levels. Mol Cell Endocrinol 246: 121-127.
13. Puzianowska-Kuznicka M, Pietrzak M, Turowska O, Nauman A, (2006) Thyroid hormones and their receptors in the regulation of cell proliferation. Acta Biochim Pol 53: 641-650.
14. Gauthier K, Plateroti M, Harvey CB, Williams GR, Weiss RE, et al. (2001) Genetic analysis reveals different functions for the products of the thyroid hormone receptor alpha locus. Mol Cell Biol 21: 4748-4760.
15. Plateroti M, Kress E, Mori JI, Samarut J, (2006) Thyroid hormone receptor alpha1 directly controls transcription of the beta-catenin gene in intestinal epithelial cells. Mol Cell Biol 26: 3204-3214.
16. Kress E, Rezza A, Nadjar J, Samarut J, Plateroti M, (2009) The frizzled-related sFRP2 gene is a target of thyroid hormone receptor alpha1 and activates beta-catenin signaling in mouse intestine. J Biol Chem 284: 1234-1241.
17. Gottardi CJ, Wong E, Gumbiner BM, (2001) E-cadherin suppresses cellular transformation by inhibiting beta-catenin signaling in an adhesion-independent manner. J Cell Biol 153: 1049-1060.
18. Brantjes H, Barker N, van Es J, Clevers H, (2002) TCF: Lady Justice casting the final verdict on the outcome of Wnt signalling. Biol Chem 383: 255-261.
19. Widelitz R, (2005) Wnt signaling through canonical and non-canonical pathways: recent progress. Growth Factors 23: 111-116.
20. de Lau W, Barker N, Clevers H, (2007) WNT signaling in the normal intestine and colorectal cancer. Front Biosci 12: 471-491.
21. Radtke F, Clevers H, (2005) Self-renewal and cancer of the gut: two sides of a coin. Science 307: 1904-1909.
22. Beildeck ME, Gelmann EP, Byers SW, (2010) Cross-regulation of signaling pathways: an example of nuclear hormone receptors and the canonical Wnt pathway. Exp Cell Res 316: 1763-1772.
23. Mulholland DJ, Dedhar S, Coetzee GA, Nelson CC, (2005) Interaction of nuclear receptors with the Wnt/beta-catenin/Tcf signaling axis: Wnt you like to know? Endocr Rev 26: 898-915.
24. Guigon CJ, Zhao L, Lu C, Willingham MC, Cheng SY, (2008) Regulation of beta-catenin by a novel nongenomic action of thyroid hormone beta receptor. Mol Cell Biol 28: 4598-4608.
25. Shah S, Islam MN, Dakshanamurthy S, Rizvi I, Rao M, et al. (2006) The molecular basis of vitamin D receptor and beta-catenin crossregulation. Mol Cell 21: 799-809.
26. Botrugno OA, Fayard E, Annicotte JS, Haby C, Brennan T, et al. (2004) Synergy between LRH-1 and beta-catenin induces G1 cyclin-mediated cell proliferation. Mol Cell 15: 499-509.
27. Chesire DR, Isaacs WB, (2002) Ligand-dependent inhibition of beta-catenin/TCF signaling by androgen receptor. Oncogene 21: 8453-8469.
28. Easwaran V, Pishvaian M, Salimuddin, Byers S, (1999) Cross-regulation of beta-catenin-LEF/TCF and retinoid signaling pathways. Curr Biol 9: 1415-1418.
29. Fodde R, Edelmann W, Yang K, van Leeuwen C, Carlson C, et al. (1994) A targeted chain-termination mutation in the mouse Apc gene results in multiple intestinal tumors. Proc Natl Acad Sci U S A 91: 8969-8973.
30. Gaspar C, Fodde R, (2004) APC dosage effects in tumorigenesis and stem cell differentiation. Int J Dev Biol 48: 377-386.
31. Bianco AC, Kim BW, (2006) Deiodinases: implications of the local control of thyroid hormone action. J Clin Invest 116: 2571-2579.
32. Gereben B, Zavacki AM, Ribich S, Kim BW, Huang SA, et al. (2008) Cellular and molecular basis of deiodinase-regulated thyroid hormone signaling. Endocr Rev 29: 898-938.
33. Kengaku M, Capdevila J, Rodriguez-Esteban C, De La Pena J, Johnson RL, et al. (1998) Distinct WNT pathways regulating AER formation and dorsoventral polarity in the chick limb bud. Science 280: 1274-1277.
34. Rezza A, Skah S, Roche C, Nadjar J, Samarut J, et al. (2010) The overexpression of the putative gut stem cell marker Musashi-1 induces tumorigenesis through Wnt and Notch activation. J Cell Sci 123: 3256-3265.
35. Arce L, Yokoyama NN, Waterman ML, (2006) Diversity of LEF/TCF action in development and disease. Oncogene 25: 7492-7504.
36. Waterman ML, (2004) Lymphoid enhancer factor/T cell factor expression in colorectal cancer. Cancer Metastasis Rev 23: 41-52.
37. Samuels HH, Stanley F, Casanova J, (1979) Depletion of L-3,5,3′-triiodothyronine and L-thyroxine in euthyroid calf serum for use in cell culture studies of the action of thyroid hormone. Endocrinology 105: 80-85.
38. Korinek V, Barker N, Morin PJ, van Wichen D, de Weger R, et al. (1997) Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma. Science 275: 1784-1787.
39. Mahmoudi T, Boj SF, Hatzis P, Li VS, Taouatas N, et al. (2011) The leukemia-associated Mllt10/Af10-Dot1l are Tcf4/beta-catenin coactivators essential for intestinal homeostasis. PLoS Biol 8: e1000539.
40. Hu MC, Rosenblum ND, (2005) Smad1, beta-catenin and Tcf4 associate in a molecular complex with the Myc promoter in dysplastic renal tissue and cooperate to control Myc transcription. Development 132: 215-225.
41. Gregorieff A, Clevers H, (2005) Wnt signaling in the intestinal epithelium: from endoderm to cancer. Genes Dev 19: 877-890.
42. Cianferotti L, Cox M, Skorija K, Demay MB, (2007) Vitamin D receptor is essential for normal keratinocyte stem cell function. Proc Natl Acad Sci U S A 104: 9428-9433.
43. Amir AL, Barua M, McKnight NC, Cheng S, Yuan X, et al. (2003) A direct beta-catenin-independent interaction between androgen receptor and T cell factor 4. J Biol Chem 278: 30828-30834.
44. Song LN, Herrell R, Byers S, Shah S, Wilson EM, et al. (2003) Beta-catenin binds to the activation function 2 region of the androgen receptor and modulates the effects of the N-terminal domain and TIF2 on ligand-dependent transcription. Mol Cell Biol 23: 1674-1687.
45. Jansson EA, Are A, Greicius G, Kuo IC, Kelly D, et al. (2005) The Wnt/beta-catenin signaling pathway targets PPARgamma activity in colon cancer cells. Proc Natl Acad Sci U S A 102: 1460-1465.
46. El-Tanani M, Fernig DG, Barraclough R, Green C, Rudland P, (2001) Differential modulation of transcriptional activity of estrogen receptors by direct protein-protein interactions with the T cell factor family of transcription factors. J Biol Chem 276: 41675-41682.
47. Palmer HG, Gonzalez-Sancho JM, Espada J, Berciano MT, Puig I, et al. (2001) Vitamin D[3] promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of beta-catenin signaling. J Cell Biol 154: 369-387.
48. Cheng SY, Leonard JL, Davis PJ, (2010) Molecular aspects of thyroid hormone actions. Endocr Rev 31: 139-170.
49. Fre S, Pallavi SK, Huyghe M, Lae M, Janssen KP, et al. (2009) Notch and Wnt signals cooperatively control cell proliferation and tumorigenesis in the intestine. Proc Natl Acad Sci U S A 106: 6309-6314.
50. Yokota J, (2000) Tumor progression and metastasis. Carcinogenesis 21: 497-503.
51. Buob D, Fauvel H, Buisine MP, Truant S, Mariette C, et al. (2011) The Complex Intratumoral Heterogeneity of Colon Cancer Highlighted by Laser Microdissection. Dig Dis Sci In print.
52. Clevers H, (2006) Wnt/beta-catenin signaling in development and disease. Cell 127: 469-480.
53. Evans GS, Flint N, Somers AS, Eyden B, Potten CS, (1992) The development of a method for the preparation of rat intestinal epithelial cell primary cultures. J Cell Sci 101: 219-231.
54. Staal FJ, Noort Mv M, Strous GJ, Clevers HC, (2002) Wnt signals are transmitted through N-terminally dephosphorylated beta-catenin. EMBO Rep 3: 63-68.
55. van Noort M, Meeldijk J, van der Zee R, Destree O, Clevers H, (2002) Wnt signaling controls the phosphorylation status of beta-catenin. J Biol Chem 277: 17901-17905.